When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRSP - Editas adds to Celgene collaboration-stoked up move shares ahead 4%
CRISPR Therapeutics AG
CRISPR/Cas9 gene editor Editas Medicine (EDIT+4%) is up on average volume, adding to yesterday's 9% jump after it announced an amended collaboration agreement with Celgene (CELG) aimed at researching, developing and commercializing autologous and allogeneic alpha-beta T cell therapies for cancer and autoimmune diseases that will earn it an upfront $70M payment.
More news on: Editas Medicine, Inc., Celgene Corporation, Intellia Therapeutics, Inc., Healthcare stocks news, Stocks on the move,